Effect of mesuprine hydrochloride upon nonpregnant uterine contractility and the cardiovascular system.
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D008656:Mestranol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009640:Norethindrone / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013610:Tachycardia / Q000139:chemically induced; D014599:Uterus / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D000605:Amino Alcohols; D010627:Phenethylamines; D013449:Sulfonamides; D008656:Mestranol; D009640:Norethindrone